Pasar al contenido principal

NANOTERMOMETRO INTRACELULAR PARA EL ESTUDIO TERMICO DE LA FISIOLOGIA CELULAR Y TERAPIA DEL CANCER POR HIPERTEMIA MAGNETICA LOCAL

PID2021-124354NB-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal para Impulsar la Investigación Científico-Técnica y su Transferencia
Subprograma Subprograma Estatal de Generación de Conocimiento
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2021
Plan Estatal 2021-2023 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Local Temperature Increments and Induced Cell Death in Intracellular Magnetic Hyperthermia

  • Gu, Yuanyu
  • Piñol, Rafael
  • Moreno-Loshuertos, Raquel
  • Brites, Carlos
  • Zeler, Justyna
  • Martínez, Abelardo
  • Maurin-Pasturel, Guillaume
  • Fernández-Silva, Patricio
  • Marco-Brualla, Joaquín
  • Téllez, Pedro
  • Cases, Rafael
  • Navarro, Rafael
  • Bonvin, Debora
  • Carlos, Luis D.
  • Millán, Ángel
The generation of temperature gradients on nanoparticles heated externally by a magnetic field is crucially important in magnetic hyperthermia therapy. But the intrinsic low heating power of magnetic nanoparticles, at the conditions allowed for human use, is a limitation that restricts the general implementation of the technique. A promising alternative is local intracellular hyperthermia, whereby cell death (by apoptosis, necroptosis, or other mechanisms) is attained by small amounts of heat generated at thermosensitive intracellular sites. However, the few experiments conducted on the temperature determination of magnetic nanoparticles have found temperature increments that are much higher than the theoretical predictions, thus supporting the local hyperthermia hypothesis. Reliable intracellular temperature measurements are needed to get an accurate picture and resolve the discrepancy. In this paper, we report the real-time variation of the local temperature on γ-Fe2O3 magnetic nanoheaters using a Sm3+/Eu3+ ratiometric luminescent thermometer located on its surface during exposure to an external alternating magnetic field. We measure maximum temperature increments of 8 °C on the surface of the nanoheaters without any appreciable temperature increase on the cell membrane. Even with magnetic fields whose frequency and intensity are still well within health safety limits, these local temperature increments are sufficient to produce a small but noticeable cell death, which is enhanced considerably as the magnetic field intensity is increased to the maximum level tolerated for human use, consequently demonstrating the feasibility of local hyperthermia., This work was supported by the Spanish Ministry of Science Innovation and Universities [Grants Nos. PGC2018_095795_B_I00 and PID2021-124354NB-I00] and the Diputación General de Aragón [Grants Nos. LMP220_21 and E11/17R]. It is also developed within the scope of the projects CICECO-Aveiro Institute of Materials, UIDB/50011/2020, UIDP/50011/2020, and LA/P/0006/2020, and Shape of Water (PTDC/NAN-PRO/3881/2020) financed by Portuguese funds through the FCT/MEC (PIDDAC). The support of the European Union’s Horizon 2020 FET Open program under grant agreement numbers 801305 (NanoTBTech) and 829162 (Hotzymes) is also acknowledged. The authors would like to acknowledge the use of the Servicio General de Apoyo a la Investigación-SAI, University of Zaragoza., Peer reviewed
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Local temperature increments and induced cell death in intracellular magnetic hyperthermia

  • Gu, Y.
  • Piñol, R.
  • Moreno-Loshuertos, R.
  • Brites, C. D. S.
  • Zeler, J.
  • Martínez, A.
  • Maurin-Pasturel, G.
  • Fernández-Silva, P.
  • Marco-Brualla, J.
  • Téllez, P.
  • Cases, R.
  • Navarro Belsué, R.
  • Bonvin, D.
  • Carlos, L. D.
  • Millán, Á.
The generation of temperature gradients on nanoparticles heated externally by a magnetic field is crucially important in magnetic hyperthermia therapy. But the intrinsic low heating power of magnetic nanoparticles, at the conditions allowed for human use, is a limitation that restricts the general implementation of the technique. A promising alternative is local intracellular hyperthermia, whereby cell death (by apoptosis, necroptosis, or other mechanisms) is attained by small amounts of heat generated at thermosensitive intracellular sites. However, the few experiments conducted on the temperature determination of magnetic nanoparticles have found temperature increments that are much higher than the theoretical predictions, thus supporting the local hyperthermia hypothesis. Reliable intracellular temperature measurements are needed to get an accurate picture and resolve the discrepancy. In this paper, we report the real-time variation of the local temperature on γ-Fe2O3 magnetic nanoheaters using a Sm3+/Eu3+ ratiometric luminescent thermometer located on its surface during exposure to an external alternating magnetic field. We measure maximum temperature increments of 8 °C on the surface of the nanoheaters without any appreciable temperature increase on the cell membrane. Even with magnetic fields whose frequency and intensity are still well within health safety limits, these local temperature increments are sufficient to produce a small but noticeable cell death, which is enhanced considerably as the magnetic field intensity is increased to the maximum level tolerated for human use, consequently demonstrating the feasibility of local hyperthermia.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Enhanced luminescence of (Eu3+/Sm3+)(diketone)3(N-Base) complexes enabled by ancillary ligands

  • Maurin-Pasturel, Guillaume
  • Piñol, Rafael
  • Cases, Rafael
  • Brites, Carlos D.S.
  • Saraiva, Leonardo F.
  • Carneiro Neto, Albano N.
  • Ara, Irene
  • Falvello, Larry
  • Sanjuán, Marisa
  • Carlos, Luís D.
  • Millán, Angel
Lanthanide β-diketonate complexes are prominent luminescent materials due to their intense, spectrally pure emissions and their broad utility in sensing, display technologies, and photonics. Their efficiency, however, depends critically on the effectiveness of ligand-to-metal energy transfer and the suppression of non-radiative deactivation. Introducing ancillary N-donor ligands enhances these processes by improving energy-transfer efficiency and reducing vibrational quenching. We report a family of Eu3+ and Sm3+ complexes of general formula LnL3L*, where L is a β-diketonate (4,4,4- trifluoro-1-phenyl-1,3-butanedionate, btfa− , or 2-thenoyltrifluoroacetate, tta− ) and L* a bidentate (1,10-phenanthroline) or tridentate (terpyridine derivatives) N-donor ligand. The complexes were synthesized and characterized by single-crystal and powder X-ray diffraction, Raman, and IR spectroscopies. Photophysical measurements, supported by computational analysis, reveal clear structure–property correlations. All complexes exhibit markedly enhanced emission relative to the parent LnL3⋅2H2O species (Ln = Eu and Sm). The highest luminescence intensities were obtained with 4′(4-methyl)-2,2′:6′,2″-terpyridine, followed by 1,10-phenanthroline, 2,2′:6′,2″-terpyridine, and 2,6-bis(5-(p-methoxyphenyl)-1H-pyrazol-3-yl)pyridine. Overall, these results highlight the critical role of ancillary N-donor ligands in tuning lanthanide photophysics, thereby enabling enhanced emission efficiency and tailored optical properties for advanced luminescent technologies.
Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Clinical and molecular characterization of a novel pathogenic AIFM1 E336K mutation connecting mitochondrial dysfunction and neurodegeneration

  • Ferrer, Miguel
  • Pedrón, María
  • Soriano, Olga
  • Martínez-Julvez, Marta
  • Marín-Baquero, Mikel
  • García-Villanueva, Rut
  • Velázquez-Campoy, Adrián
  • Marco-Brualla, Joaquín
  • Ripollés-Yuba, Cristina
  • Fernández-Silva, Patricio
  • Medina, Milagros
  • Miramar, María Dolores
  • Bestué, María
  • Moreno-Loshuertos, Raquel
  • Ferreira, Patricia
Mutations in the AIFM1 gene, encoding the apoptosis-inducing factor (AIF), have been associated with a spectrum of neurometabolic disorders. However, the mechanistic basis underlying their pathogenicity remains poorly understood. In this work, we identified and comprehensively characterized a novel hemizygous AIFM1 mutation c.1006G > A (E336K) in a male patient presenting with a progressive hereditary axonal sensorimotor polyneuropathy with childhood onset, inherited in an X-linked recessive pattern, associated with sensorineural hearing loss and without cognitive impairment. The clinical phenotype was consistent with Charcot-Marie-Tooth disease type 4 (CMTX4). Patient-derived fibroblasts exhibited reduced AIF protein stability despite preserved mRNA expression, impaired growth in OXPHOS-dependent conditions, decreased basal respiration, and altered assembly of mitochondrial respiratory supercomplexes. These defects were accompanied by reduced CHCHD4 protein levels and mitochondrial content. The purified E336K protein exhibited compromised FAD retention, decreased thermal stability, impaired NADH affinity, destabilization of the charge-transfer complex crucial for sustaining the AIF: CHCHD4 interaction, and a shift in coenzyme preference toward NADPH. Structurally, the substitution of Glu336 with Lys remodels the electrostatic environment of the NADH-binding cleft, thereby compromising redox function and weakening CHCHD4 binding. Despite these defects, the protein with the E336K mutation retained DNA binding, nuclease activity, and binding to nuclear partners, although parthanatos induction was attenuated in patient fibroblasts. Collectively, these molecular alterations converge on defective mitochondrial bioenergetics and dynamics, providing a direct mechanistic link to the patient’s clinical evolution. These findings provide a framework for understanding AIFM1-related disorders and pave the way for the development of future personalized molecular therapies.